RenovoRx (RNXT) Appoints Robert J. Spiegel to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. LDOS
8. AXP
9. AON
10. TMUS

Go back to RenovoRx (RNXT) Appoints Robert J. Spiegel to its Board

RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors

April 27, 2023 8:30 AM EDT

LOS ALTOS, Calif.--(BUSINESS WIRE)-- RenovoRx, Inc. (RenovoRx or the Company) (Nasdaq: RNXT), a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced pancreatic cancer (LAPC), announced today that Robert J. Spiegel, MD, has been appointed to the Companys Board of Directors, effective April 25, 2023.

Dr. Spiegel brings more... More